Screening for trisomies by cell-free DNA testing of maternal blood: Consequences of a failed result

Ultrasound in Obstetrics and Gynecology

Volumn 47, Issue 6, 2016, Pages 698-704

  Revello, R ^a   Sarno, L ^a   Ispas, A ^a   Akolekar, R ^a,b   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b MEDWAY MARITIME HOSPITAL   (United Kingdom)

Author keywords

cell free DNA; fetal fraction; first trimester screening; non invasive prenatal testing; trisomy 21

Indexed keywords

DNA;

BLOOD; BODY MASS; CELL FREE SYSTEM; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME DISORDERS; COHORT ANALYSIS; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; GENETICS; HUMAN; MATERNAL AGE; MATERNAL SERUM SCREENING TEST; PREDICTIVE VALUE; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; RISK FACTOR; TRISOMY;

BODY MASS INDEX; CELL-FREE SYSTEM; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; COHORT STUDIES; DNA; DOWN SYNDROME; FEMALE; HUMANS; MATERNAL AGE; MATERNAL SERUM SCREENING TESTS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RISK FACTORS; TRISOMY;

EID: 84971524818     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.15851     Document Type: Article

References (22)

1. Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH,. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 249-266.
2. Pergament E, Cuckle H, Zimmermann B, Banjevic M, Sigurjonsson S, Ryan A, Hall MP, Dodd M, Lacroute P, Stosic M, Chopra N, Hunkapiller N, Prosen DE, McAdoo S, Demko Z, Siddiqui A, Hill M, Rabinowitz M,. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet Gynecol 2014; 124: 210-218.
3. American College of Obstetricians and Gynecologists. Cell-free DNA screening for fetal aneuploidy. Committee Opinion No. 640. Obstet Gynecol 2015; 126: e31-37.
4. Gil MM, Revello R, Poon LC, Akolekar R, Nicolaides KH,. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test. Ultrasound Obstet Gynecol 2016; 47: 45-52.
5. Quezada MS, Gil MM, Francisco C, Oròsz G, Nicolaides KH,. Screening for trisomies 21, 18 and 13 cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks. Ultrasound Obstet Gynecol 2015; 45: 36-41.
6. Robinson HP, Fleming JE,. A critical evaluation of sonar crown rump length measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
7. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH,. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383.
8. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH,. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31: 493-502.
9. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A,. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 319.e1-9.
10. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH,. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 322.e1-5.
11. Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH,. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis. Ultrasound Obstet Gynecol 2013; 41: 21-25.
12. Ashoor G, Poon L, Syngelaki A, Mosimann B, Nicolaides KH,. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: Effect of maternal and fetal factors. Fetal Diagn Ther 2012; 31: 237-243.
13. Ashoor G, Poon L, Syngelaki A, Mosimann B, Nicolaides KH,. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013; 41: 26-32.
14. Poon LC, Musci T, Song K, Syngelaki A, Nicolaides KH,. Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagn Ther 2013; 33: 215-223.
15. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA,. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet Med 2011; 13: 913-920.
16. Wegrzyn P, Faro C, Falcon O, Peralta CF, Nicolaides KH,. Placental volume measured by three-dimensional ultrasound at 11 to 13+ 6 weeks of gestation: relation to chromosomal defects. Ultrasound Obstet Gynecol 2005; 26: 28-32.
17. Bevilacqua E, Gil MM, Nicolaides KH, Ordoñez E, Cirigliano V, Dierickx H, Willems PJ, Jani JC,. Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies. Ultrasound Obstet Gynecol 2015; 45: 61-66.
18. Chaveeva P, Carbone IF, Syngelaki A, Akolekar R, Nicolaides KH,. Contribution of method of conception on pregnancy outcome after the 11-13 weeks scan. Fetal Diagn Ther 2011; 30: 9-22.
19. Rava RP, Srinivasan A, Sehnert AJ, Bianchi DW,. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem 2014; 60: 243-250.
20. Dar P, Curnow KJ, Gross SJ, Hall MP, Stosic M, Demko Z, Zimmermann B, Hill M, Sigurjonsson S, Ryan A, Banjevic M, Kolacki PL, Koch SW, Strom CM, Rabinowitz M, Benn P,. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014; 211: 527.e1-17.
21. Palomaki GE, Kloza EM, Lambert-Messerlian GM, van den Boom D, Ehrich M, Deciu C, Bombard AT, Haddow JE,. Circulating cell free DNA testing: are some test failures informative? Prenat Diagn 2015; 35: 289-293.
22. Kinnings SL, Geis JA, Almasri E, Wang H, Guan X, McCullough RM, Bombard AT, Saldivar JS, Oeth P, Deciu C,. Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing. Prenat Diagn 2015; 35: 816-822.